Italian Real Life Experience with Brentuximab Vedotin: Results of a National Observational Study on Relapsed/Refractory Anaplastic Large Cell Lymphoma

被引:0
|
作者
Pellegrini, Cinzia [1 ]
Rigacci, Luigi [2 ]
Patti, Caterina [3 ]
Gini, Guido [4 ]
Mannina, Donato [5 ]
Tani, Monica [6 ]
Rusconi, Chiara [7 ]
Romano, Alessandra [8 ]
Vanazzi, Anna [9 ]
Botto, Barbara [10 ]
Carlo-Stella, Carmelo [11 ]
Hohaus, Stefan [12 ]
Rigolin, Gian Matteo [13 ]
Musto, Pellegrino [14 ]
Mazza, Patrizio [15 ]
Molica, Stefano
Corradini, Paolo [16 ]
Fama, Angelo [17 ]
Gaudio, Francesco [18 ]
Merli, Michele [19 ]
Gravetti, Angela [20 ]
Gritti, Giuseppe [21 ]
Arcari, Annalisa [22 ]
Tosi, Patrizia [23 ]
Liberati, Anna Marina [24 ]
Pinto, Antonello [25 ]
Pavone, Vincenzo [26 ]
Gherlinzoni, Filippo [27 ]
Naso, Virginia [28 ]
Volpetti, Stefano [29 ]
Visentin, Andrea [30 ]
Goldaniga, Maria Cecilia [31 ]
Bonfichi, Maurizio [32 ]
De Renzo, Amalia [33 ]
Schiavotto, Corrado [34 ]
Spina, Michele [35 ]
Storti, Sergio [36 ]
Carella, Angelo Michele [37 ]
Argnani, Lisa [1 ]
Zinzani, Pier Luigi [1 ]
机构
[1] Univ Bologna, Inst Hematol L e A Seragnoli, Bologna, Italy
[2] Univ & Hosp Careggi, Dept Hematol, Florence, Italy
[3] Dept Hematol, Azienda Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy
[4] Ospedali Riuniti Ancona, Dept Hematol, Ancona, Italy
[5] Osped Papardo, Hematol Unit, Messina, Italy
[6] Santa Maria Croci Hosp, Hematol Unit, Ravenna, Santa Maria, RS, Italy
[7] Osped Niguarda Ca Granda, Div Hematol, Milan, Italy
[8] AOU, Div Haematol, Catania, Italy
[9] European Inst Oncol, Milan, Italy
[10] Azienda Ospedaliera Univ Citta Salute Scienza, SC Ematologia, Turin, Italy
[11] Humanitas Clin & Res Ctr, Humanitas Canc Ctr, Oncol & Hematol, Rozzano, Italy
[12] Cathol Univ, Inst Hematol, Rome, Italy
[13] Univ Ferrara, Hematol Sect, Azienda Ospedaliero Univ S Anna, Ferrara, Italy
[14] CROB Rionero Vulture, Rome, Italy
[15] Osped Moscati Dept Hematol Oncol, Taranto, Italy
[16] Fondazione IRCCS Ist Nazl Tumori, Dept Hematol, Milan, Italy
[17] Ist Ricovero Cura Carattere Scientifico, Hematol Unit, Arcispedale Santa Maria Nuova, Reggio Emilia, Italy
[18] Policlinico Bari, Hematol Unit, Bari, Italy
[19] Fondazione Macchi, Hematol, Osped Circolo, Varese, Italy
[20] Cardarelli Hosp, Div Hematol, Stem Cell Transplantat Unit, Naples, Italy
[21] Hosp Papa Giovanni XXIII, Dept Hematol, Bergamo, Italy
[22] Guglielmo da Saliceto Hosp, Div Hematol, Piacenza, Italy
[23] Infermi Hosp Rimini, Hematol Unit, Rimini, Italy
[24] Osped Perugia, Hematol, Perugia, Italy
[25] IRCCS, Natl Canc Inst, Hematol Oncol & Stem Cell Transplantat Unit, Fondazione Pascale, Naples, Italy
[26] Osped G Panico, Div Hematol, Tricase, Lecce, Italy
[27] Ca Foncello Hosp, Hematol Unit, Treviso, Italy
[28] SantAndrea Hosp Sapienza, Rome, Italy
[29] DISM, Azienda Sanitaria Univ Integrata, Dept Hematol, Udine, Italy
[30] Univ Padua, Dept Med, Hematol & Clin Immunol Unit, Padua, Italy
[31] Fondazione Ca Granda IRCCS Osped Maggiore Policli, OncoHematol Unit, Milan, Italy
[32] IRCCS Policlinico San Matteo, Hematol, Pavia, Italy
[33] AOU Federico II Napoli, Hematol, Naples, Italy
[34] San Bortolo Hosp, Hematol, Vicenza, Italy
[35] Natl Canc Inst, Div Med Oncol, Aviano, Italy
[36] Univ Cattolica Sacro Cuore Campobasso, Hematol, Campobasso, Italy
[37] IRCCS San Martino IST, Div Hematol 1, Genoa, Italy
关键词
D O I
10.1182/blood.V128.22.3007.3007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3007
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma
    Broccoli, Alessandro
    Pellegrini, Cinzia
    Di Rocco, Alice
    Puccini, Benedetta
    Patti, Caterina
    Gini, Guido
    Mannina, Donato
    Tani, Monica
    Rusconi, Chiara
    Romano, Alessandra
    Vanazzi, Anna
    Botto, Barbara
    Carlo-Stella, Carmelo
    Hohaus, Stefan
    Musto, Pellegrino
    Mazza, Patrizio
    Molica, Stefano
    Corradini, Paolo
    Fama, Angelo
    Gaudio, Francesco
    Merli, Michele
    Gravetti, Angela
    Gritti, Giuseppe
    Arcari, Annalisa
    Tosi, Patrizia
    Liberati, Anna Marina
    Pinto, Antonello
    Pavone, Vincenzo
    Gherlinzoni, Filippo
    Naso, Virginia
    Volpetti, Stefano
    Trentin, Livio
    Goldaniga, Maria Cecilia
    Bonfichi, Maurizio
    De Renzo, Amalia
    Schiavotto, Corrado
    Spina, Michele
    Storti, Sergio
    Carella, Angelo Michele
    Stefoni, Vittorio
    Argnani, Lisa
    Zinzani, Pier Luigi
    HAEMATOLOGICA, 2017, 102 (11) : 1931 - 1935
  • [2] REAL LIFE EXPERIENCE WITH BRENTUXIMAB VEDOTIN: THE ITALIAN STUDY ON 40 RELAPSED/REFRACTORY ANAPLASTIC LARGE CELL LYMPHOMA PATIENTS
    Quirini, F.
    Broccoli, A.
    Pellegrini, C.
    Di Rocco, A.
    Puccini, B.
    Patti, C.
    Gini, G.
    Mannina, D.
    Tani, M.
    Rusconi, C.
    Romano, A.
    Vanazzi, A.
    Botto, B.
    Carlo-Stella, C.
    Hoaus, S.
    Musto, P.
    Mazza, P.
    Molica, S.
    Corradini, P.
    Fama, A.
    Gaudio, F.
    Merli, M.
    Gravetti, A.
    Gritti, G.
    Arcari, A.
    Tosi, P.
    Liberati, A. M.
    Pinto, A.
    Pavone, V.
    Gherlinzoni, F.
    Naso, V.
    Volpetti, S.
    Trentin, L.
    Goldaniga, M. C.
    Bonfichi, M.
    De Renzo, A.
    Schiavotto, C.
    Spina, M.
    Storti, S.
    Carella, A. M.
    Stefoni, V.
    Argnani, L.
    Zinzani, P. L.
    HAEMATOLOGICA, 2017, 102 : 50 - 51
  • [3] Italian Real Life Experience with Brentuximab Vedotin: Results of a National Observational Study on Relapsed/Refractory Hodgkin's Lymphoma
    Broccoli, Alessandro
    Pulsoni, Alessandro
    Rigacci, Luigi
    Patti, Caterina
    Gini, Guido
    Mannina, Donato
    Tani, Monica
    Rusconi, Chiara
    Romano, Alessandra
    Vanazzi, Anna
    Botto, Barbara
    Santoro, Armando
    Hohaus, Stefan
    Rigolin, Gian Matteo
    Musto, Pellegrino
    Mazza, Patrizio
    Molica, Stefano
    Corradini, Paolo
    Fama, Angelo
    Gaudio, Francesco
    Merli, Michele
    Ronconi, Fioravante
    Gritti, Giuseppe
    Vallisa, Daniele
    Tosi, Patrizia
    Liberati, Anna Marina
    Pinto, Antonello
    Pavone, Vincenzo
    Gherlinzoni, Filippo
    Cavalieri, Elena
    Volpetti, Stefano
    Visentin, Andrea
    Goldaniga, Maria Cecilia
    Bonfichi, Maurizio
    De Renzo, Amalia
    Schiavotto, Corrado
    Spina, Michele
    Carella, Angelo Michele
    Argnani, Lisa
    Zinzani, Pier Luigi
    BLOOD, 2016, 128 (22)
  • [4] Italian real life experience with brentuximab vedotin: results of a large observational study on 234 relapsed/refractory Hodgkin's lymphoma
    Pellegrini, Cinzia
    Broccoli, Alessandro
    Pulsoni, Alessandro
    Rigacci, Luigi
    Patti, Caterina
    Gini, Guido
    Mannina, Donato
    Tani, Monica
    Rusconi, Chiara
    Romano, Alessandra
    Vanazzi, Anna
    Botto, Barbara
    Santoro, Armando
    Hoaus, Stefan
    Rigolin, Gian Matteo
    Musto, Pellegrino
    Mazza, Patrizio
    Molica, Stefano
    Corradini, Paolo
    Fama, Angelo
    Gaudio, Francesco
    Merli, Michele
    Ronconi, Fioravante
    Gritti, Giuseppe
    Vallisa, Daniele
    Tosi, Patrizia
    Liberati, Anna Marina
    Pinto, Antonello
    Pavone, Vincenzo
    Gherlinzoni, Filippo
    Bianchi, Maria Paola
    Volpetti, Stefano
    Trentin, Livio
    Goldaniga, Maria Cecilia
    Bonfichi, Maurizio
    De Renzo, Amalia
    Schiavotto, Corrado
    Spina, Michele
    Carella, Angelo Michele
    Stefoni, Vittorio
    Argnani, Lisa
    Zinzani, Pier Luigi
    ONCOTARGET, 2017, 8 (53) : 91703 - 91710
  • [5] Relapsed or refractory anaplastic large cell lymphoma: Brentuximab vedotin of course!
    Paillassa, Jerome
    HEMATOLOGIE, 2018, 24 (01): : 19 - 21
  • [6] REAL LIFE EXPERIENCE WITH BRENTUXIMAB VEDOTIN: THE ITALIAN STUDY ON 234 RELAPSED/REFRACTORY HODGKIN'S LYMPHOMA
    Stefoni, V.
    Pulsoni, A.
    Rigacci, L.
    Patti, C.
    Gini, G.
    Mannina, D.
    Tani, M.
    Rusconi, C.
    Romano, A.
    Vanazzi, A.
    Botto, B.
    Santoro, A.
    Hoaus, S.
    Rigolin, G. M.
    Pellegrino, M.
    Mazza, P.
    Molica, S.
    Corradini, P.
    Fama, A.
    Gaudio, F.
    Merli, M.
    Ronconi, F.
    Gritti, G.
    Vallisa, D.
    Tosi, P.
    Liberati, A. M.
    Pinto, A.
    Pavone, M. C. V.
    Gherlinzoni, F.
    Bianchi, M. P.
    Volpetti, S.
    Trentin, L.
    Goldaniga, M.
    Bonfichi, M.
    De Renzo, A.
    Schiavotto, C.
    Spina, M.
    Carella, A. M.
    Argnani, L.
    Zinzani, P. L.
    HAEMATOLOGICA, 2017, 102 : 29 - 29
  • [7] Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma
    Pro, Barbara
    Advani, Ranjana
    Brice, Pauline
    Bartlett, Nancy L.
    Rosenblatt, Joseph D.
    Illidge, Tim
    Matous, Jeffrey
    Ramchandren, Radhakrishnan
    Fanale, Michelle
    Connors, Joseph M.
    Fenton, Keenan
    Huebner, Dirk
    Pinelli, Juan M.
    Kennedy, Dana A.
    Shustov, Andrei
    BLOOD, 2017, 130 (25) : 2709 - 2717
  • [8] Brentuximab vedotin: treatment role for relapsed refractory systemic anaplastic large-cell lymphoma
    Lai, Chao-Ming
    Horowitz, Sandra
    EXPERT REVIEW OF HEMATOLOGY, 2013, 6 (04) : 361 - 373
  • [9] Cost-effectiveness of brentuximab vedotin in relapsed or refractory systemic anaplastic large cell lymphoma
    Hux, Margaret
    Zou, Denise
    Ma, Esprit
    Sajosi, Peter
    Engstrom, Andreas
    Selby, Ross
    Benson, Eugene
    Teasell, Jeremy
    Richhariya, Akshara
    Briggs, Andrew
    Bonthapally, Vijayveer
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (07)
  • [10] BRENTUXIMAB VEDOTIN DESENSITIZATION IN A FEMALE WITH RELAPSED, REFRACTORY, ANAPLASTIC LARGE-CELL LYMPHOMA (ALCL)
    Qamar, N.
    Cho, S.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2012, 109 (05) : A68 - A68